Allenex AB Year-End Report 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Allenex AB (STO:ALNX):

For the fourth quarter October-December

•Net sales for the quarter amounted to SEK 29.4 million (27.4). Sales were impacted by a positive currency effect of SEK 0.3 million compared to the same period last year.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC